![](https://scx1.b-cdn.net/csz/news/tmb/2024/novel-drug-application.jpg)
Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
Relapsed/refractory acute myeloid leukemia (AML), a blood cancer, has an extremely poor prognosis because of resistance to anti-cancer drugs and frailty of the patient's organ functions. A type of anti-tumor immunotherapy ...
Jul 18, 2024
0
0